Even as Roche makes a major investment pledge across its U.S. business, the Swiss pharmaceutical giant isn’t neglecting its ...

The dollar has weakened against rival currencies since Trump started his second term. One strategist says the US currency is ...

For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech ...

Roche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...

A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal ...

As the nearly 130-year-old pharmaceutical company consolidated its CRM systems, it cut down on vendor costs and paved the way ...

Zealand Pharma announces closing of collaboration and license agreement with Roche ...

The device helps identify NSCLC subjects who are likely to benefit from Daiichi Sankyo and AstraZeneca’s Datroway’s treatment ...

The Prime Minister finally has a new chief science adviser, almost a year after his former adviser stepped down. Ministry of ...